Skip to main content

Table 3 Biochemical assessment of between studied groups (n = 120)

From: Evaluation of platelets activity and reactivity as risk factors for acute ischemic non-embolic stroke in young adults

Laboratory investigations Patients without risk factors (A1) (n = 37) Patients with risk factors (A2) (n = 23) Healthy controls (n = 60) Test value p-value Post hoc between A1 and A2
RBS (mg/dl) Mean ± SD 115.6 ± 52.7 145.6 ± 87.2 110.1 ± 28 F = 3.98 0.02* 0.049*
Range 81–218 75–379 74–188
Creatinine (mg/dl) Mean ± SD 0. 74 ± 0.2 0.88 ± 0.2 0.59 ± 1.6 F = 12.2 < 0.001* 0.02*
Range 0.3–1.2 0.5–2 0.3–1
Total cholesterol (mg/dl) Mean ± SD 174.2 ± 38.7 194.1 ± 49.9 138.8 ± 52.2 F = 12.7 < 0.001* 0.28
Range 93–224 103–313 55–215
TG (mg/dl) Mean ± SD 125.4 ± 51.7 165.8 ± 82.5 98.3 ± 31.9 F = 14.3 < 0.001* 0.01*
Range 47–262 66–324 54–201
LDL (mg/dl) Mean ± SD 110.5 ± 36.6 124.2 ± 48.3 95.1 ± 27.6 F = 6.1 0.003* 0.35
Range 39–224 51–233 45–164
HDL (mg/dl) Mean ± SD 35.5 ± 8.7 36.9 ± 7.9 32.7 ± 8.7 F = 2.37 0.098 0.83
Range 13–54 25–60 12–51
  1. *One-way ANOVA (analysis of variance) is statistically significant at level of significance of 95%. (p < 0.05). RBS random blood sugar, TG triglycerides, LDL low-density lipoprotein, HDL high-density lipoprotein
  2. bold indicates statistically significant relation
  3. italic indicates the type of the test used